Other Species / Isoforms
  RALB (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S6-p
__MAANKskGQSSLA
0 2
RALB (human) __MAANKskGQSSLA S6-p
RALB (mouse) __MAANKGKsQGsLV G6
RALB (rat) __MAANKGKSQGSLV G6
K7-ub
_MAANKskGQSSLAL
0 2
RALB (human) _MAANKskGQSSLAL K7-ub
RALB (mouse) _MAANKGKsQGsLVL K7
RALB (rat) _MAANKGKSQGSLVL K7
G8
MAANKskGQSSLALH
0 2
RALB (human) MAANKskGQSSLALH G8
RALB (mouse) MAANKGKsQGsLVLH S8-p
RALB (rat) MAANKGKSQGSLVLH S8
S11
NKskGQSSLALHKVI
0 3
RALB (human) NKskGQSSLALHKVI S11
RALB (mouse) NKGKsQGsLVLHKVI S11-p
RALB (rat) NKGKSQGSLVLHKVI S11
S22-p
HKVIMVGsGGVGKSA
0 3
RALB (human) HKVIMVGsGGVGKSA S22-p
RALB (mouse) HKVIMVGSGGVGKSA S22
RALB (rat) HKVIMVGSGGVGKSA S22
Y43-p
YDEFVEDyEPTkADS
Upstream
0 10
Treatment
  • imatinib
RALB (human) YDEFVEDyEPTkADS Y43-p
RALB (mouse) YDEFVEDYEPTKADS Y43
RALB (rat) YDEFVEDYEPTKADS Y43
K47-ub
VEDyEPTkADSyRKK
1 0
RALB (human) VEDyEPTkADSyRKK K47-ub
RALB (mouse) VEDYEPTKADSYRKK K47
RALB (rat) VEDYEPTKADSYRKK K47
Y51-p
EPTkADSyRKKVVLD
0 1
RALB (human) EPTkADSyRKKVVLD Y51-p
RALB (mouse) EPTKADSYRKKVVLD Y51
RALB (rat) EPTKADSYRKKVVLD Y51
Y75-p
DTAGQEDyAAIRDNY
0 11
RALB (human) DTAGQEDyAAIRDNY Y75-p
RALB (mouse) DTAGQEDYAAIRDNY Y75
RALB (rat) DTAGQEDYAAIRDNY Y75
S85-p
IRDNYFRsGEGFLLV
0 1
RALB (human) IRDNYFRsGEGFLLV S85-p
RALB (mouse) IRDNYFRSGEGFLLV S85
RALB (rat) IRDNYFRSGEGFLLV S85
T104-p
EHESFTAtAEFREQI
0 1
RALB (human) EHESFTAtAEFREQI T104-p
RALB (mouse) EHESFTATAEFREQI T104
RALB (rat) EHESFTATAEFREQI T104
K120-ub
RVKAEEDkIPLLVVG
0 1
RALB (human) RVKAEEDkIPLLVVG K120-ub
RALB (mouse) RVKSEEDKIPLLVVG K120
RALB (rat) RVKAEEDKIPLLVVG K120
K129-ub
PLLVVGNkSDLEERR
0 1
RALB (human) PLLVVGNkSDLEERR K129-ub
RALB (mouse) PLLVVGNKSDLEERR K129
RALB (rat) PLLVVGNKSDLEERR K129
K146-ub
PVEEARSkAEEWGVQ
0 1
RALB (human) PVEEARSkAEEWGVQ K146-ub
RALB (mouse) PVDEARGKAEEWGVQ K146
RALB (rat) PVEEARGKAEEWGVQ K146
Y154-p
AEEWGVQyVETSAkT
0 1
RALB (human) AEEWGVQyVETSAkT Y154-p
RALB (mouse) AEEWGVQYVETSAkT Y154
RALB (rat) AEEWGVQYVETSAKT Y154
K160-ub
QyVETSAkTRANVDK
1 2
RALB (human) QyVETSAkTRANVDK K160-ub
RALB (mouse) QYVETSAkTRANVDK K160-ub
RALB (rat) QYVETSAKTRANVDk K160
K179-ac
LMREIRTkkMSENKD
0 1
RALB (human) LMREIRTkkMSENKD K179-ac
RALB (mouse) LMREIRAKKMSENKD K179
RALB (rat) LMREIRAKKMSENKD K179
K180-ac
MREIRTkkMSENKDK
0 1
RALB (human) MREIRTkkMSENKDK K180-ac
RALB (mouse) MREIRAKKMSENKDK K180
RALB (rat) MREIRAKKMSENKDK K180
K190-ac
ENKDKNGkKSSKNKK
0 1
RALB (human) ENKDKNGkKSSKNKK K190-ac
RALB (mouse) ENKDKNGRKSSKSKK R190
RALB (rat) ENKDKNGRKSGKSKK R190
S198-p
KSSKNKKsFKERCCL
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • carcinogenesis, altered
  • cell growth, altered
  • cell motility, altered
  • cytoskeletal reorganization
Kinase, in vitro:
  • PKCA (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • Go_6983
  • phorbol_ester
RALB (human) KSSKNKKsFKERCCL S198-p
RALB (mouse) KSSKSKKSFKERCCL S198
RALB (rat) KSGKSKKSFKERCCL S198